WILKES-BARRE, LUZERNE COUNTY (WBRE/WYOU) — October is Breast Cancer Awareness Month, and the state’s Department of Health made a stop in Wilkes-Barre on Monday to take a closer look at new breast ...

A Chicago doctor is using new FDA-approved technology that makes cancer cells glow during surgery. Here's how it works.

Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a ...

PORTSMOUTH — Portsmouth Regional Hospital, part of HCA Healthcare, recently provided staff, physicians and the public with the opportunity to explore the latest advancements in the diagnosis and ...

According to the American Cancer Society, lung cancer is the deadliest cancer in the United States and the second most common type of cancer. A promising new approach could change that: advanced ...

Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers? It is also noteworthy that patients can ...

COLUMBUS, Ohio (WCMH) — A new study from The James Cancer Hospital at Ohio State is showing promising results for improving precise tumor removal in complex cancer patients. Head and neck cancer ...

Cancer detection and treatment research will receive up to $115 million for three projects funded under agreements between the Advanced Research Projects Agency for Health (ARPA-H) and Rice University ...

PHOENIX - New technology is improving the way Breast Cancer surgery is done. "We wanted to get away from the wired technology, and that's where the industry has moved now to what we call ‘wireless ...

Jennifer Greenman discusses how to leverage technology already in place for cancer care needs, as well as City of Hope's acquisition of CTCA. Editor's note: This conversation is a transcript from an ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Ozone is like Earth’s natural sunscreen, protecting living ...

Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).